Full opinion text
LINN, Circuit Judge. Medtronic Sofamor Danek, Inc. et al. (“Medtronic”) appeals from an order of the United States District Court for the Central District of California (“district court”) permanently enjoining Medtronic from infringing claim 5 of U.S. Patent No. 5,474,-555 (“the ’555 patent”) owned by Cross Medical Products, Inc. (“Cross Medical”). See Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D.Cal. Sept. 28, 2004). The permanent injunction was issued following the grant of Cross Medical’s motions for partial summary judgment of validity and infringement. See Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D.Cal. Aug. 19, 2004) (“Invalidity Opinion ”); Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., No. SA CV 03-110-GLT(ANx) (C.D.Cal. May 20, 2004) (“Infringement Opinion”). As a threshold matter, we conclude, over Cross Medical’s objection, that we have jurisdiction over this appeal. On Medtronic’s challenge to the district court’s claim construction rulings, we affirm the district court’s construction of the “anchoring means,” “securing means,” and “bear against said channel” limitations, but modify the district court’s construction of the “anchor seat means” and “operatively joined” limitations. Because we find genuine issues of material fact regarding infringement, we reverse the grant of Cross Medical’s motion for partial summary judgment of infringement and find no abuse of discretion in the denial of Med-tronic’s cross-motion for partial summary judgment of non-infringement. We also reverse the grant of Cross Medical’s motion for partial summary judgment that claim 5 is not obvious but affirm the grant of that motion as to indefiniteness and anticipation. We further conclude that the district court did not abuse its discretion in denying Medtronic’s cross-motion for summary judgment as to these invalidity issues. Consequently, we vacate the permanent injunction. Thus, we affirm-in-part, reverse-in-part, vacate-in-part, and remand. I. BACKGROUND This appeal involves orthopedic surgical implants used to stabilize and align the bones of a patient’s spine. A common problem with spinal fixation is determining how to secure the fixation device to the spine without damaging the spinal cord. Methods of fixation have developed which utilize wires that extend through the spinal canal and hold a rod against the lamina, or that utilize pedicular screws which extend into the pedicle and secure a plate which extends across vertebral segments. The system taught in U.S. Patent No. 4,805,602 (“the ’602 patent”), which is also assigned to Cross Medical and is part of the case against Medtronic but not involved in this appeal, exemplifies the advantages of both method’s. The screw and rod system of the ’602 patent provides a rigidity which is intermediate between wired implant and plate systems. Several screw and rod systems are known in the art. Those which feature an anchor secured to the bone by a separate screw are termed “polyaxial.” Polyaxial screws have a capability of pivoting in the anchor. Devices in which the anchor and the bone screw form a unitary body are deemed “monoaxial.” Monoaxial screws have no ability to pivot relative to the anchor. Cross Medical’s ’555 patent discloses a device, an embodiment of which is illustrated in Figures 1, 2, and 3 below: The ’555 device allows a surgeon to place a series of bone screws 21, each carrying an anchor seat 23, into the bones of a patient. A stabilization rod 18 thereafter may be positioned in the channels 51, 52 of the anchor seats. The ’555 device allows surgeons to secure the rod to the anchor seats with top-tightening nuts 27. By connecting the rod in this fashion to the anchors on adjacent spinal bones, the position of the patient’s spine may be fixed as desired by the surgeon. On February 4, 2003, Cross Medical filed suit alleging that certain of Medtronic’s polyaxial screws-MAS, Vertex, M8, Sextant, M10, Legacy 4.5, and Legacy 5.5 — infringe the ’555 patent and U.S. Patent No. 5,466,237 (“the ’237 patent”). The accused devices employ a “set screw,” which features external threads to mate with the receiver member’s internal threads, to hold the rod in the receiver member. The accused devices also include a “crown member” that lies between the rod and the bone screw. An illustration of the accused device follows, with explanatory text added. Medtronic denied infringement and counterclaimed seeking a declaratory judgment of non-infringement and invalidity. Subsequent to the initial pleading, responses and amended pleadings added claims and counterclaims relating to several additional patents, including the ’602 patent. The district court resolved several issues through summary adjudication. Of importance to this appeal, the district court separately entertained motions for partial summary judgment of infringement and validity of claim 5 of the ’555 patent. Claim 5 recites: A fixation device for the posterior stabilization of one or more bone segments of the spine, comprising: at least two anchors and an elongated stabilizer comprising a rod having a diameter and a longitudinal axis, said anchors each comprising anchoring means which secure said anchors to said bone segment and an anchor seat means which has a lower bone interface opera-tively joined to said bone segment and an anchor seat portion spaced apart from said bone interface including a channel to receive said rod; and securing means which cooperate with each of said anchor seat portions spaced apart from said bone interface and exterior to the bone relative to said elongated rod, said seat means including a vertical axis and first threads which extend in the direction of said vertical axis toward said lower bone interface to a depth below the diameter of the rod when it is in the rod receiving channel, and said securing means including second threads which cooperate with the first threads of the seat means to cause said rod to bear against said channel through the application of substantially equal compressive forces by said securing means in the direction of the vertical axis and applied on either side along said longitudinal axis of said channel. ’555 patent, col. 8, 11. 38-57 (emphases added). On May 29, 2004, the district court construed the “operatively joined,” “securing means,” and “bear against said channel” limitations of claim 5 of the ’555 patent. Based on these constructions, the court granted Cross Medical’s motion for partial summary judgment of infringement, and denied Medtronic’s cross-motion for partial summary judgment of non-infringement. On August 19, 2004, the district court additionally construed the “anchor seat means” and “anchoring means” limitations of claim 5 of the ’555 patent. The court then denied Medtronic’s motion for partial summary judgment that claim 5 was anticipated, obvious, and indefinite, and granted Cross Medical’s cross-motion for partial summary judgment that claim 5 was neither anticipated, obvious, nor indefinite. On September 28, 2004, with proceedings still on-going with respect to the ’555 patent and other patents-in-suit, the district court granted Cross Medical’s motion for a permanent injunction to preclude Medtronic’s infringement of claim 5 of the ’555 patent. The district court presumed irreparable harm because Cross Medical had prevailed on the merits at the summary judgment stage. Medtronic argued that there could be no harm because it withdrew all of the asserted infringing devices from the market; however, the district court found that some of the infringing products remained available and that Medtronic had the capacity to bring infringing product back to market. On October 4, 2004, the district court stayed the injunction for 90 days to allow Med-tronic time to appeal. On October 13, 2004, Medtronic appealed from the order granting the injunction, asserting jurisdiction under 28 U.S.C. § 1292(a)(1), (c)(1). Medtronic asks this court to review the district court’s claim construction rulings, reverse or vacate the district court’s partial summary judgment orders on infringement, indefiniteness, anticipation, and obviousness with respect to claim 5 of the ’555 patent, and vacate the permanent injunction. On November 19, 2004, Cross Medical filed a motion to dismiss this appeal for lack of jurisdiction. II. DISCUSSION A. Jurisdiction “Whether this court has jurisdiction over an appeal taken from a district court judgment is a question of law which we address in the first instance.” Pause Tech. LLC v. TiVo Inc., 401 F.3d 1290, 1292 (Fed.Cir.2005). Section 1292(a)(1) provides that the court of appeals has jurisdiction over appeals from interlocutory orders “granting, continuing, modifying, refusing or dissolving injunctions, or refusing to dissolve or modify injunctions.” 28 U.S.C. § 1292(a)(1) (2000). Section 1292(c)(1) provides this court exclusive jurisdiction over an appeal of an interlocutory order granting an injunction if we would otherwise have jurisdiction under § 1295. Id. § 1292(c)(1). Medtronic appeals from an order permanently enjoining Medtronic from infringing the ’555 patent. On its face, the order falls within the scope of § 1292(a)(1), (c)(1). Cross Medical argues that under Woodard v. Sage Products, Inc., 818 F.2d 841 (Fed.Cir.1987) (en banc), this court does not possess jurisdiction because the injunction is one in form but not substance. Cross Medical asserts that the injunction is not coercive because it enjoins Medtronic from engaging in activities it had abandoned before the injunction issued. Cross Medical asserts that Medtronic simply should have sought a stay of the injunction pending appeal under Federal Rule of Appellate Procedure 8(a). Alternatively, Cross Medical argues that even if the court has jurisdiction to review the order, it has no jurisdiction to reverse or vacate the partial summary judgment rulings because no final judgment on the ’555 patent has been entered, and the orders were not certified for appeal. Medtronic counters that the order falls under § 1292(a)(1), (c)(1). Medtronic asserts that Sage Products is inapposite and that no case has denied jurisdiction in an appeal from the grant of an injunction. Medtronic states that Cross Medical argued below that the injunction was necessary to prevent irreparable harm, that Medtronic pulled products from the market to avoid a willfulness finding, that the district court entered the injunction with full knowledge of Medtronic’s actions, and that it would be unfair to deny Medtronic its statutory right of appeal. Cross Medical’s reliance on Sage Products is misplaced. In Sage Products, plaintiffs amended complaint included a prayer for injunctive relief, and the issue was whether plaintiff could lodge an appeal under § 1292(a)(1) from an order granting defendant’s motion for summary judgment of non-infringement. 818 F.2d at 843-44. There was no order specifically denying injunctive relief. Id. Instead, plaintiff argued that the adverse summary judgment ruling had the effect of denying injunctive relief. Id. at 844. This court sitting en banc considered the impact of the Supreme Court’s then recent decision in Carson v. American Brands, Inc., 450 U.S. 79, 101 S.Ct. 993, 67 L.Ed.2d 59 (1981). We explained that Carson “instructed that an interlocutory appeal under section 1292(a)(1) requires (a) that the order be injunctive in nature, (b) that it cause a serious, if not irreparable, consequence, and (c) that the order can be effectively challenged only by immediate appeal.” Sage Products, 818 F.2d at 849. We held that Woodard failed to establish that the order met the Carson requirements. Id. at 855. However, in reporting on how other courts interpreted Carson, we criticized the Seventh Circuit for applying “the Carson requirements to an order explicitly granting an injunction,” observing that “the Supreme Court in Carson expressly limited its holding to orders that have ‘the practical effect of refusing an injunction.’ ” Id. at 850 n. 6 (quoting Carson, 450 U.S. at 84, 101 S.Ct. 993). We explained that “as a rale of general applicability to orders deemed to deny injunctions, the Carson rule is workable and sensibly balances the statutory provisions of sections 1291 and 1292(a)(1) in light of their respective purposes.” Id. at 853. The Supreme Court subsequently confirmed our reading of Carson as applying only to orders that have “the practical effect of granting or denying injunctions.” Gulfstream Aerospace Corp. v. Mayacamas Corp., 485 U.S. 271, 287-88, 108 S.Ct. 1133, 99 L.Ed.2d 296 (1988) (“Section 1292(a)(1) will, of course, continue to provide appellate jurisdiction over orders that grant or deny injunctions and orders that have the practical effect of granting or denying injunctions and have ‘ “serious, perhaps irreparable, consequence.” ’ ” (quoting Carson, 450 U.S. at 84, 101 S.Ct. 993 (quoting Baltimore Contractors v. Bodinger, 348 U.S. 176, 181, 75 S.Ct. 249, 99 L.Ed. 233 (1955)))); see also 19 James Wm. Moore et ah, Moore’s Federal Practice ¶ 203.10[2][a], at 12 (3d ed. 2005) (“Moore’s ”) (“While the statute clearly applies to orders that formally grant injunctive relief, it also authorizes interlocutory appeals from orders that have the practical effect of granting an injunction.”). Therefore, “if the district court’s order expressly grants an injunction, the order is appealable under § 1292(a)(1), without regard to whether the appellant is able to demonstrate serious or irreparable consequences.” Moore’s ¶ 203.10[2][a], at 14. In this case, the district court entered an order expressly enjoining Medtronic from infringing claim 5 of the ’555 patent. Thus, Carson is inapplicable. See PIN/NIP, Inc. v. Platte Chem. Co., 304 F.3d 1235, 1242 (Fed.Cir.2002) (finding jurisdiction without referring to the Carson test because “[t]he district court’s grant of a permanent injunction ... [brought the] appeal squarely within the confines of § 1292(a)(1)”). On appeal from the district court’s grant of the injunction, we have jurisdiction under 28 U.S.C. § 1292(a)(1). Moreover, we may review the underlying partial summary judgment orders because they are inseparably connected to the merits of the permanent injunction. See id. at 1242^8 (reviewing a summary judgment ruling that a claim was not anticipated by the prior art where jurisdiction was based on § 1292(a)(1), (c)(1)); Katz v. Lear Siegler, Inc., 909 F.2d 1459, 1461 (Fed.Cir.1990) (reviewing propriety of join-der of counter-defendant on appeal from injunction); Moore’s ¶ 203.10[7][b], at 45-47 (“[An interlocutory appeal under § 1292(a)(1) ] enable[s] the circuit court to review other orders that are inseparably or very closely connected with the merits of the injunctive order .... ”). The district court presumed irreparable harm based on Cross Medical’s success on the merits, which manifested itself in the summary judgment orders concerning claim 5. Because Cross Medical’s success on the merits turns on the propriety of the summary judgment rulings, our review of the grant of the permanent injunction requires that we rule on the summary judgment orders. See Mendenhall v. Barber-Greene Co., 26 F.3d 1573, 1581 n. 12 (Fed.Cir.1994) (noting “that an interlocutory appeal from a permanent injunction, to the extent that it considers questions of validity and infringement ... is identical in substance to an appeal brought under § 1292(c)(2)”). The cases cited by Cross Medical are not germane. For these reasons, Cross Medical’s motion to dismiss the appeal for lack of jurisdiction is denied. B. Standard of Review “We review the grant of a permanent injunction for an abuse of discretion which requires plenary review of the correctness of ... rulings on matters of law.” Stratos Mobile Networks USA, LLC v. United States, 213 F.3d 1375, 1379 (Fed.Cir.2000) (internal quotations omitted). We review the grant of a motion for summary judgment de novo. Id. However, we review the denial of a motion for summary judgment for abuse of discretion. Gart v. Logitech, Inc., 254 F.3d 1334, 1338 (Fed.Cir.2001). Summary judgment should only be granted “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c). In applying this standard, “[t]he evidence of the non-mov-ant is to be believed, and all justifiable inferences are to be drawn in [the non-movant’s] favor.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). “The fact that both the parties have moved for summary judgment does not mean that the court must grant summary judgment to one party or the other.... Cross-motions are no more than a claim by each party that it alone is entitled to summary judgment, and the court must evaluate each motion on its own merits, taking care in each instance to view the evidence in favor of the nonmoving party.” Bubble Room, Inc. v. United States, 159 F.3d 553, 561 (Fed.Cir.1998) (internal citation omitted); accord Gart, 254 F.3d at 1338-39. Claim construction is a question of law reviewed de novo. See Phillips v. AWH Corp., 415 F.3d 1303, 1328 (Fed.Cir.2005) (en banc). Determination of infringement is a factual question. Bai v. L & L Wings, Inc., 160 F.3d 1350, 1353 (Fed.Cir.1998). “Indefiniteness, ... like claim construction, is a question of law that we review de novo.” Atmel Corp. v. Info. Storage Devices, 198 F.3d 1374, 1378 (Fed.Cir.1999). Anticipation is a question of fact. Advanced Display Sys., Inc. v. Kent State Univ., 212 F.3d 1272, 1281 (Fed.Cir.2000). “Obviousness is a question of law based on underlying facts.” Group One Ltd. v. Hallmark Cards, Inc., 407 F.3d 1297, 1303 (Fed.Cir.2005). C. Claim Construction In the course of its rulings on partial summary judgment for both infringement and validity, the district court construed the “anchoring means,” “anchor seat means,” “operatively joined,” “securing means,” and “bear against said channel” limitations of claim 5. Medtronic challenges each construction. 1. “anchors each comprising anchoring means ... and anchor seat means” In the district court, the parties disputed whether either the “anchoring means” limitation or “anchor seat means” limitation imposed a requirement that the bone screws be polyaxial. The district court did not construe each limitation separately. Instead, the district court referred to its prior ruling in Cross Medical Products, Inc. v. DePuy AcroMed, Inc., No. SA CV 00-876-GLT(ANx), (C.D.Cal. Jan. 9, 2003), and explained that both the “anchoring means” and “anchor seat means” limitations were in § 112, ¶ 6 form and “must be construed by referring to the specification.” Invalidity Opinion at 3-4. The district court held that “although the claim language itself does not indicate whether the screws are polyaxial or monoaxial, the specifications and the drawings establish that the claims are limited to polyaxial screws.” Id. at 3. Medtronic asserts that although the preferred embodiment describes a polyaxial screw, there is no basis to read this feature into claim 5 because neither “anchoring means” nor “anchor seat means” are § 112, ¶ 6 limitations. Medtronic argues that even if these are § 112, ¶ 6 limitations, a monoaxial screw is an alternative embodiment and, thus, should be considered corresponding structure, citing Micro Chemical, Inc. v. Great Plains Chemical Co., 194 F.3d 1250 (Fed.Cir.1999). Med-tronic also relies on the doctrine of claim differentiation, arguing that the recitation in claim 1 of a polyaxial screw limitation implies that claim 5 does not possess that limitation. Finally, Medtronic adds that Cross Medical is estopped from denying that claim 5 covers monoaxial screws because Cross Medical marked its monoaxial screws with the ’555 patent number. Cross Medical counters that both “anchoring means” and “anchor seat means” are § 112, ¶ 6 limitations and their corresponding structure is a polyaxial screw. Cross Medical argues that claim differentiation must give way to a proper § 112, ¶ 6 analysis and that the court should not consider “marking estoppel” in construing claim 5 because marking is extrinsic evidence. Cross Medical adds that claims should be construed to preserve their validity. The limitations at issue are contained in the following text of claim 5: said anchors each compris[e] anchoring means which secure said anchors to said bone segment and an anchor seat means which has a lower bone interface opera-tively joined to said bone segment and an anchor seat portion spaced apart from said bone interface including a channel to receive said rod.... ... said seat means including a vertical axis and first threads which extend in the direction of said vertical axis toward said lower bone interface to a depth below the diameter of the rod when it is in the rod receiving channel ’555 patent, col. 8, 11. 36-43, 46-51 (emphases added). a. “anchoring means” The limitation recites the word “means,” which gives rise to the presumption that § 112, ¶ 6 applies. See Rodime PLC v. Seagate Tech., Inc., 174 F.3d 1294, 1302 (Fed.Cir.1999). The claimed function of the “anchoring means” is to “secure said anchors to said bone segment.” ’555 patent, col. 8,11. 38-39. No structure is recited in the claim to perform this function. See id., 11. 35-56. Thus, § 112, ¶ 6 applies and the “claim shall be construed to cover the corresponding structure ... described in the specification and equivalents thereof.” 35 U.S.C. § 112, ¶ 6 (2000); Al-Site Corp. v. VSI Int’l, Inc., 174 F.3d 1308, 1320 (Fed.Cir.1999). The specification discloses only one embodiment. That embodiment contains a screw which carries a separate anchor such that “when the screw 21 engages the anchor seat 23, a limited ball-and-socket joint is formed which permits freedom of movement between the rod support 23 and the screw 21.” ’555 patent, col. 5, 11. 4-47. The specification unambiguously states that a feature of the “present invention” is that “[e]ach anchor seat is secured by a cancellous screw which cooperates through a sloped bore in the anchor seat so as to provide a limited ball and socket motion.” Id., col. 1, 1. 65-col. 2,1. 21. It continues: The present invention utilizes a rod and vertebral anchors which holds [sic] the rod in position. Each anchor is secured to the vertebrae by a transpedi-cular screw member. ... [T]he present design utilizes two implant sets on either side of the spi-nous processes. Each implant set includes a ... rod .... Generally, an implant set is used on each side of the spinous process .... The rod is held in position by a stainless steel vertebral anchor which captures the rods. The anchor has a seat member which is secured to the vertebrae by a stainless steel transpedicular screw. The screw is separate from the anchor seat and thus provides for limited motion between the anchor seat and the vertebrae. Id., col. 3,11. 26-67 (emphasis added). The patent discloses no other structure for securing the anchor to the bone. The patent states that the polyaxial design “acts as a ‘shock-absorber’ to prevent direct transfer of load from the rod to the bone-screw interface prior to achieving bony fusion, thereby decreasing the chance of failure.” Id., 11. 63-67. Thus, the district court was correct both in linking the recited function to the structure disclosed in the specification and in concluding that the corresponding structure was polyaxial. Medtronic argues that even if the limitation is a means-plus-function limitation linked to the disclosed polyaxial structure, the claim nonetheless should be construed to include alternative structures like monoaxial screws. However, because there is only one embodiment described in the specification to secure the anchor to the bone — a polyaxial screw and anchor structure— there is no basis on which to extend the limitation to cover alternative, non-disclosed structure not shown to be structurally equivalent. See 35 U.S.C. § 112, ¶ 6; Al-Site, 174 F.3d at 1320. We reject the parties’ remaining arguments. First, although the doctrine of claim differentiation suggests that claim 5 should be broader than claim 1, any presumption that the claims differ with respect to this feature may be overcome by a contrary construction mandated by the application of § 112, ¶ 6. See Laitram Corp. v. Rexnord, Inc., 939 F.2d 1533, 1538 (Fed.Cir.1991) (holding that the doctrine of claim differentiation yields to an interpretation mandated by § 112, ¶ 6). Second, Medtronic’s assertion that “marking estoppel” applies is incorrect. Even if Cross Medical marked monoaxial screws with the ’555 patent number, such evidence conflicts with the intrinsic record and has no bearing on our construction. See Phillips, 415 F.3d at 1318 (“[A] court should discount [extrinsic evidence] that is clearly at odds with the claim construction mandated by the claims themselves, the written description, and the prosecution history, in other words, with the written record of the patent.” (internal quotation omitted)); cf. SmithKline Diagnostics v. Helena Labs. Corp., 859 F.2d 878, 890-91 (Fed.Cir.1988) (holding that an accused in-fringer’s mis-marking of a product could not convert by estoppel an admittedly non-infringing product into an infringing product). Finally, Cross Medical’s argument that we should consider the validity of claim 5 in construing the limitation misses the mark. Because the other claim construction tools unambiguously resolve the claim construction dispute, considering validity would be improper. Phillips, 415 F.3d at 1327 (“[W]e have limited the maxim [of construing a claim to preserve its validity] to cases in which ‘the court concludes, after applying all the available tools of claim construction, that the claim is still ambiguous.’ ”). b. “anchor seat means” While the limitation recites the word “means,” thus giving rise to the presumption that § 112, ¶ 6 applies, see Rodime, 174 F.3d at 1302, the claim language is sufficiently structural as to take the limitation out of the ambit of § 112, ¶ 6. Thus, the district court erred in treating “anchor seat means” as a means-plus-function limitation; however, that error is harmless with respect to the conclusion that the claim covers polyaxial structures, based on the district court’s correct construction of the “anchoring means” limitation, discussed supra. 2. “operatively joined ” The district court construed “lower bone interface operatively joined to said bone segment” to mean “eonnect[ed] during a surgical procedure.” Infringement Opinion at 5. The district court interpreted “connect” to mean “in contact.” See id. & n. 2. The district court reasoned that because the claim involves a surgical procedure, “operatively” means “involving surgical operations.” Id. The district court explained that construing “operatively” to mean “to produce an appropriate effect” would improperly import a limitation from the specification. Id. at 4-5. Medtronic argues that the “bone interface” language surrounding the phrase “operatively joined” requires that there be contact between the bone segment and the anchor seat. Medtronic asserts that “op-eratively” means to produce an effect and that effect is micro-motion, which Med-tronic describes as “limited motion” between the anchor and the bone. Medtronic argues that it would be inconsistent to construe claim 5 to require a polyaxial screw which enables polyaxial movement, but not to require a micro-motion effect. Medtronic adds that the district court’s construction renders “operatively” superfluous because the only way to attach the screw to bone is via surgery. Cross Medical counters that the “bone interface” is the portion of the anchor seat that comes into contact with the bone when there is contact, but that “bone interface” does not require contact. Cross Medical argues that the district court correctly construed “operatively” to mean “surgically.” Cross Medical asserts that even if we construe “operatively” to mean “effectively,” the effect is posterior stabilization, not micro-motion. Cross Medical adds that “polyaxiar and “micro-motion” are not synonymous. The claim recites an “anchor seat means which has a lower bone interface operatively joined to said bone segment.” ’555 patent, col. 8, 11. 89-42. The claim does not state explicitly whether the “bone interface” and the “bone segment” must be in contact. However, we may refer to the dictionary to begin understanding the ordinary meaning of these claim terms, “so long as the dictionary definition does not contradict any definition found in or ascertained by a reading of the patent documents.” Phillips, 415 F.3d at 1322-23 (internal quotations omitted). “[B]one” modifies “interface,” indicating that the anchor seat has a “lower” portion that may share a “common boundary” with “bone.” See Webster’s Third New Int’l Dictionary 1178 (2002) (defining “interface”). The term “joined” describes the relationship between the “bone interface” and the “bone segment.” Use of the word “joined” indicates that the “interface” and the “bone” must be brought together or connected to form a single unit, a whole, or a continuity, and thus that the interface and the bone are in contact. See id. at 1218 (defining “join”). The written description confirms that the interface must contact the bone. The screw is separate from the anchor seat, which prevents the direct transfer of load from the rod to the “bone-screw interface,” and decreases the chance of failure of the “bone-screw interface.” Id., col. 3, 11. 19-22, 11. 64-67. This use of the term “interface” is consistent with its meaning a “common boundary” between two parts. Moreover, the patent refers to the “anchor” as being held, ’555 patent, Abstract, or “secured” to the bone, id., col. 3, 11. 59-60, and to the point of attachment as a “fusion bed,” id., col. 7,1. 15. These references suggest contact between the anchor seat and the bone. Furthermore, to adjust the height of the anchor posterior to the bone, the patent teaches the addition of washers that are the same diameter as the anchor seat. Id., col. 5, 11. 50-57. The washers eo-act with the anchor seat to function as the bone interface while elevating the seat. If contact with bone were not contemplated, then there would be little need to add washers to elevate the seat. The drawings show contact between the anchor and bone, which is consistent with the description. Id., Figures 3, 14, 17-20. Because the ordinary meaning of “interface” and “joined,” as reflected in dictionary definitions and in the overall context of the intrinsic record, leads to the conclusion that a person of ordinary skill in the art would have understood these terms to require “contact” between the interface and the bone, the district court’s construction in this regard was correct. It would be improper to construe “joined” more broadly to mean “connected” without requiring contact. As to “operatively,” the term is often used descriptively in patent drafting to mean “effectively” in describing the functional relationship between claimed components. See, e.g., Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1118 (Fed.Cir.2004) (“[Opera-tively connected] is a general descriptive term frequently used in patent drafting to reflect a functional relationship between claimed components.”). Here, the preamble of the claim recites that the invention is operative when it effects posterior stabilization of one or more bone segments of the spine. ’555 patent, col. 8, 11. 33-34; see Innova, 381 F.3d at 1118 (declining to decide whether preamble was an affirmative limitation, but recognizing that preamble recited the intended use corresponding to “operatively”). The body of the claim is consistent as it calls for anchors and a stabilizer rod, and provides detail on how these structures interrelate to stabilize the bone segment. See ’555 patent, col. 8, 11. 35-57; Innova, 381 F.3d at 1118-19 (looking to the body of the claim to understand the purpose). Although the written description does not define “operatively,” it consistently describes the purpose of the device to be for posterior stabilization. See ’555 patent, col. 1, 11. 9-12 (“This invention relates generally to an apparatus for immobilization of the spine, and more particularly, to an apparatus for posterior internal fixation of the spine .... ”); Inno-va, 381 F.3d at 1118-19 (looking to the written description to understand the purpose). It discusses disadvantages of prior art spinal fixation methods and apparatuses, ’555 patent, col. 1,11. 13-64; col. 2,1. 36-col. 3, 1. 25, details how the invention’s features provide an advantageous fixation system, id., col. 3, 1. 26-col. 6, 1. 44, and provides a method of spinal fixation therapy for use with the device, id., col. 6,1. 45-col. 7,1. 50. Therefore, from the context of the written description, it is clear that one of ordinary skill in the art would have understood “operatively” to mean effective to produce posterior stabilization. The district court erred in construing “operatively” to mean “surgically.” Because the only way a “fixation device” can provide “posterior stabilization” is through a surgical procedure, construing “operatively” to mean “surgically” renders the word superfluous, as used in the claim. For all of these reasons, we modify the district court’s claim construction and conclude that, in claim 5, the “lower bone interface [is] operatively joined to said bone segment” when the interface and the bone segment are connected and in contact such that the device is effective to perform posterior stabilization. 3. “securing means ” The district court considered the “securing means” limitation to be in § 112, ¶ 6 form, and described its function as “applying] a force to the rod, which compresses the rod against the anchor seats and secures the rod in place.” Infringement Opinion at 6. The district court explained that compression must be applied on "either side"-either inside or outside-of the rod-receiving channel. Id. at 7. The district court identified the corresponding structure as an "outer nut." Id. at 6. Medtronic argues that the district court’s interpretation of the function of the “securing means” somehow ignores the claim language: “through the application of substantially equal compressive forces ... applied on either side along said longitudinal axis of said channel,” ’555 patent, col. 8, 11. 54-57 (emphasis added). Med-tronic asserts that this language mandates that forces be applied along the longitudinal axis of the rod on “either side” of the channel and not on “either side” of the vertical axis. Medtronic interprets “either side” of the channel to be on the “outside” of the channel. Although Medtronic does not dispute that the corresponding structure is an external nut, Medtronic argues that the written description and prosecution history show a disavowal of equivalents to an external nut. Cross Medical responds that the district court did not ignore the “either side” limitation, and that, in any event, “either side” can mean that the forces are applied “inside” the channel. Cross Medical provides the illustration that standing on “either side” of the room would connote standing inside the room. Cross Medical adds that the specification and prosecution history do not evince a disavowal, and that claim differentiation doctrine supports structural equivalents. The claim requires: at least two anchors and an elongated stabilizer comprising a rod having a diameter and a longitudinal axis .... securing means which cooperate with each of said anchor seat portions ... said securing means including second threads which cooperate with the first threads of the seat means to cause said rod to bear against said channel through the application of substantially equal compressive forces by said securing means in the direction of the vertical axis and applied on either side along said longitudinal axis of said channel. ’555 patent, col. 8,11. 36-37, 44-57. We agree with the parties that the limitation is in § 112, ¶ 6 format. See Ro-dime, 174 F.3d at 1302 (noting that a concession by the parties that the claim is in § 112, ¶ 6 form does not relieve the court of its duty to examine whether § 112, ¶ 6 applies). The claim recites “securing means,” which gives rise to the presumption that § 112, ¶ 6 applies. See id. The function is “to cause said rod to bear against said channel through the application of substantially equal compressive forces by said securing means in the direction of the vertical axis and applied on either side along said longitudinal axis of said channel.” ’555 patent, col. 8, 11. 53-57. "{E]ither side" does not refer to "either side" of the rod on the vertical axis of the channel perpendicular to the rod, because that interpretation would render the "in the direction of the vertical axis" language redundant. The "and" in the phrase "in the direction of the vertical axis and applied on either side" makes that clear. Therefore, the function is to cause the rod to bear against the rod-receiving channel by applying a compressive force in the direction of the vertical axis while ensuring that substantially equal forces are applied along the longitudinal axis of the rod on opposite sides-either inside or outside-of the rod-receiving channel. We must now determine whether the claim recites structure to carry out that function. The claim states that the “securing means ... cooperate with each of said anchor seat portions,” id., 11. 44-45, in that the “securing means include[s] second threads which cooperate with the first threads of the seat means to cause [the desired function],” id., 11. 51-57. Although it is the operation of the threads that causes the rod to bear against the channel by applying a compressive force in the direction of the vertical axis, a naked incantation of threads alone does not ensure that substantially equal forces are applied along the longitudinal axis of the rod on opposite sides of the rod-receiving channel. Because there is insufficient structure recited for performing the specified function, § 112, ¶ 6 applies. Thus, we construe the claim “to cover the corresponding structure ... described in the specification and equivalents thereof.” The structure for performing the recited function is described as follows: The nut 27 includes internal threads 83 which engage the external threaded area 76 on the anchor seat. The nut 27 is a hex nut which can be tightened relative to the seat 25. As the nut 27 is rotated about the anchor seat 25, it cooperates with the top side of the flange 46,47 to tighten the clamp 25 in relation to the rod support 23. The rod 18 is grasped in the tunnel 84 formed between the rod-receiving channel 54 of the anchor seat 23 and the arch 72 of the cap 25. The threads 76 on the anchor seat 23 extend downwardly on the seat below the top of the cylindrical surface of the rod 18 as is shown in FIG. 2 and the nut 27 has a relatively constant diameter through the bore as is shown in FIGS. 2 and 4. Accordingly, the nut 27 can be screwed directly onto the anchor seat 23 to compressively hold the rod without the cap 25. ’555 patent, col. 6, 11. 9-24. Figures 5 and 7 depict the rod 18 in the channel created by the anchor seat 23, with the nut 27 securing the rod in place. Thus, the structure that corresponds to the claimed function is a nut with internal threads cooperating with the external threads of the anchor seat (an “external nut”). The claim covers that structure and equivalents thereof. We are not persuaded by Medtronic’s argument that the written description shows a disavowal of equivalents. Although we need not decide that there can never be a disavowal of § 112, ¶ 6 equivalents, “ § 112-6 was written precisely to avoid a holding that a means-plus-function limitation must be read as covering only the means disclosed in the specification.” D.M.I., Inc. v. Deere & Co., 755 F.2d 1570, 1574 (Fed.Cir.1985). In this case, the inventors were merely describing the structure that performs the claimed function. Nor are we persuaded that the prosecution history shows a disavowal. In an August 4, 1994 Office Action (“Office Action ”), the Examiner rejected the apparatus claims, in part, under § 112, ¶ 1, because “[t]he specification fail[ed] to provide an enabling description of the embodiment of the action device excluding the cap/cap means,” and because “language directed toward the ‘securing means’ cooperating with the seat means through application of compressive forces by the securing means” failed to have support in the specification. Office Action at 4. Subsequent to that rejection, an interview was held with the Examiner and the Examiner Interview Summary referred to “securing means” as “i.e., the nut.” In addition, Remarks in the April 27, 1995 Amendment (“Amendment ”) stated that Applicant amended the claims “to define the anchor seat means having a channel and threads which cooperate with the securing means (i.e., the nut) so as to capture the stabilizer between the channel and the securing means.” Amendment at 4. However, Applicant did not add language in claim 5 that limited securing means to a nut. The statements referring to “securing means” as “i.e., the nut” simply help to provide the requisite linkage between the function recited in the claim and the “corresponding” structure. See Default Proof Credit Card Sys., Inc. v. Home Depot U.S.A., Inc., 412 F.3d 1291, 1298 (Fed. Cir.2005) (“A structure disclosed in the specification qualifies as “corresponding” structure only if the specification or prosecution history clearly links or associates that structure to the function recited in the claim.”). Applicant did not disclaim all structural equivalents. Therefore, the district court correctly construed the “securing means” limitation to refer to the external nut described in the written description. Under § 112, ¶ 6, the claim also covers equivalents thereof. 4. “bear against said channel ” The parties dispute whether the language of claim 5 reciting that the “rod ... bear[s] against said channel” precludes the presence of any intervening structure between the rod and the channel. The district court held that “[t]here is nothing in the [language of claim 5] which excludes an anchor channel composed of more than one component part.” Infringement Opinion at 8. Medtronic argues that the district court’s construction is erroneous, and that by placing a separable crown member over the anchor seat, Medtronic has prevented the rod from “bearing] against [the] channel” as a matter of law. Medtronic asserts that the anchor seat must form the channel and the crown is not part of the anchor seat. Cross Medical responds that claim 5 does not require that the channel of the anchor seat be a unitary component and thus does not preclude a finding that the crown is part of the anchor seat. The dispute reduces to whether the “channel” must be formed in a unitary structure. The claim requires that the anchor seat means have “an anchor seat portion spaced apart from said bone interface including a channel to receive said rod,” ’555 patent, col. 8, 11. 41-42, and that the “securing means ... cause[s] said rod to bear against said channel,” id., 11. 51-54. The claim does not state that the anchor seat portion forming the channel is unitary. Although the sole embodiment described in the specification depicts a unitary structure, id., col. 5, 11. 20-21, the mere depiction of a structural claim feature as unitary in an embodiment, without more, does not mandate that the structural limitation be unitary. See CCS Fitness, Inc. v. Brunswick Corp., 288 F.3d 1359, 1367 (Fed.Cir.2002) (holding that “member” encompassed a multi-component structure where the preferred embodiment showed a single-component structure, but the specification did not otherwise require a certain number of components). There is nothing in the written description or prosecution history that limits the channel to being formed in a single-component structure. Thus, the district court correctly concluded that the “bear against said channel” language of claim 5 does not exclude an “anchor seat portion” composed of multiple components. D. Infringement The district court ruled as a matter of law that the accused devices met the “op-eratively joined,” “securing means,” and “bear against said channel” limitations, that Medtronic was a direct infringer, and that alternatively, Medtronic either contributed to infringement or induced infringement. Infringement Opinion at 4-9. Medtronic appeals. 1. “operatively joined ” The district court held that the accused devices met the “operatively joined” limitation as a matter of law because “ ‘the accused device, to be infringing, need only be capable of operating in the [infringing] mode ... actual [infringing] operation in the accused device is not required.’ ” Id. at 5-6 (quoting Intel Corp. v. U.S. Int’l Trade Comm'n 946 F.2d 821, 832 (Fed. Cir.1991)). The district court cited Hilgraeve Corp. v. Symantec Corp., 265 F.3d 1336, 1343 (Fed. Cir.2001), for the proposition that “an accused device may be found to infringe if it is reasonably capable of satisfying the claim limitations, even though it may also be capable of non-infringing modes of operation.” Infringement Opinion at 5. The court explained that Medtronic’s devices “are capable of operative joinder to the bone segment, and are sometimes used in this way.” Id. at 5-6. In response to Medtronic’s argument that it could not directly infringe because it did not perform surgery, the district court held that “under 35 U.S.C. § 271 Defendants can be liable for inducing the infringement or for selling a device which constitutes part of the invention.” Id. at 8. Medtronic argues that it does not itself make an anchor seat which contacts bone and it does not perform surgery. Med-tronic asserts that Intel and Hilgraeve are inapposite and that it cannot be a direct infringer simply because its accused devices are capable of being made into infringing devices by surgeons. Medtronic adds that it does not induce or contribute to infringement because there is no evidence of physicians bringing the receiver member into contact with the bone segment to make the claimed apparatus; because Medtronic does not design the receiver member to contact the bone segment; and because Medtronic instructs surgeons not to place the device into contact with the bone. Cross Medical counters that to directly infringe, Medtronic need only make devices that are capable of being converted into infringing devices, citing Intel, Hilgraeve, and Bell Com. Research Inc. v. Vitalink Com. Corp., 55 F.3d 615 (Fed.Cir.1995). Cross Medical asserts that Medtronic’s argument that it does not directly infringe because it does not perform surgery is as superficial as the non-infringement argument concerning the “Commissioner.com” product in Fantasy Sports Props., Inc. v. SportsLine.com, Inc., 287 F.3d 1108 (Fed.Cir.2002), and therefore must fail. Furthermore, Cross Medical argues that Medtronic’s representatives are present in the operating room and thus that Med-tronic performs surgery. Alternatively, Cross Medical argues that Medtronic induces infringement because it sells devices to surgeons, designs its anchors to function when in contact with bone, and intends that surgeons bring the anchor seat into contact with bone; and because surgeons actually bring the anchor seat into contact with bone. Cross Medical asserts that Medtronic is a contributory infringer because it has not proven that there are substantial non-infringing uses. “[Wjhoever without authorization makes, uses, offers to sell, or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor [directly] infringes the patent.” 35 U.S.C. § 271(a) (2000). To prove direct infringement, the plaintiff must establish by a preponderance of the evidence that one or more claims of the patent read on the accused device literally or under the doctrine of equivalents. Advanced Cardiovascular Sys., Inc. v. Scimed Life Sys., Inc., 261 F.3d 1329, 1336 (Fed.Cir.2001). “Literal infringement requires that each and every limitation set forth in a claim appear in an accused product.” Franks Casing Crew & Rental Tools, Inc. v. Weatherford Int’l, Inc., 389 F.3d 1370, 1378 (Fed.Cir.2004) (internal citation omitted). Claim 5 of the ’555 patent is an apparatus claim. See ’555 patent, col. 8, 11. 34-57. We held in Part 11.C.2 supra that the “operatively joined” limitation requires that “the interface and the bone segment are connected and in contact such that the device is effective to perform posterior stabilization.” In support of its argument that Medtronic directly infringes, Cross Medical cites evidence that Medtronic’s representatives appear in the operating room, identify instruments used by surgeons, and thus in effect “join” the anchor seat to the bone. Cross Medical argues that the situation is analogous to those in which courts have found a party to directly infringe a method claim when a step of the claim is performed at the direction of, but not by, that party. See, e.g., Shields v. Halliburton Co., 493 F.Supp. 1376, 1389 (W.D.La.1980). However, if anyone makes the claimed apparatus, it is the surgeons, who are, as far as we can tell, not agents of Medtronic. Because Medtronic does not itself make an apparatus with the “interface” portion in contact with bone, Medtronic does not directly infringe. Nor does Intel support a finding of direct infringement. The claim at issue in Intel called for a “programmable selection means” and thus required only that an accused device be capable of operating in the enumerated mode. 946 F.2d at 832; see Fantasy Sports, 287 F.3d at 1117-18; High Tech Med. Instrumentation Inc. v. New Image Indus., Inc., 49 F.3d 1551, 1555-56 (Fed.Cir.1995). Here, the claim does not require that the interface be merely “capable” of contacting bone; the claim has a structural limitation that the anchor seat be in contact with bone. See Fantasy SpoHs, 287 F.3d at 1117-18 (stressing the “programmable” language of the claim at issue in Intel and holding that Intel “does not stand for the proposition ... that infringement may be based upon a finding that an accused product is merely capable of being modified in a manner that infringes the claims of a patent”); High Tech, 49 F.3d at 1555-56 (distinguishing Intel based on the permissive language of the claim at issue). Cross Medical would distinguish High Tech by asserting that the device in that case had to be physically altered to become infringing, while Med-tronic’s device need not be altered. However, Cross Medical again fails to recognize that the limitation — the anchor seat being in contact with bone — is absent until the screw and anchor are put in place during surgery. Bell Communications and Hilgraeve are also inapposite. In Bell Communications, plaintiff asserted that defendant’s product embodied a claimed method, but the district court granted summary judgment of non-infringement reasoning that the product had non-infringing modes of operation. 55 F.3d at 618-19. In Hilgraeve, plaintiff asserted that defendant sold software that, when in operation, infringed plaintiffs method claim, but the district court granted summary judgment of non-infringement based on rationale similar to that in Bell Communications. See Hilgraeve, 265 F.3d at 1339-40. In both cases on appeal, this court held that the district court had erred by overlooking the rule that “an accused product that sometimes, but not always, embodies a claimed method nonetheless infringes.” Bell, 55 F.3d at 622-23; accord Hilgraeve, 265 F.3d at 1343 (“[S]o too the sale of a device may induce infringement of a method claim even if the accused device is capable of non-infringing modes of operation in unusual circumstances.”). However, a rule that governs infringement of a method claim may not always govern infringement of an apparatus claim. See, e.g., NTP, Inc. v. Research in Motion, Ltd., 418 F.3d 1282, 1317-18 (Fed.Cir.2005) (distinguishing between method claims and apparatus claims for the purpose of determining infringement under section 271(a)). To infringe an apparatus claim, the device must meet all of the structural limitations. See Hewlett-Packard Co. v. Bausch & Lomb, Inc., 909 F.2d 1464, 1468 (Fed.Cir.1990) (“[Apparatus claims cover what a device is, not what a device does.”); In re Michlin, 45 C.C.P.A. 1028, 256 F.2d 317, 320 (1958) (“It is well settled that patentability of apparatus claims must depend upon structural limitations and not upon statements of function.”). In this case, claim 5 is an apparatus claim which contains the structural limitation that the anchor seat contact bone. Cross Medical has not proven that Med-tronic mahes an apparatus with an anchor seat in contact with bone. Cross Medical’s reliance on Fantasy Sports is also misplaced. In Fantasy Sports, the apparatus claim called for “[a] computer for playing football.” 287 F.3d at 1111. The district court found that the accused “Commissioner.com” product did not infringe because it was a “modifiable software tool,” not a computer for playing football. See id. at 1118. We disagreed, holding that Sportsline directly infringed by making or using the apparatus because no reasonable juror could find that the “Commissioner.com” product was not software installed on a computer. See id. at 1118-19. Cross Medical argues that the theory that Medtronic does not directly infringe because it does not itself contact the anchor seat to the bone is as superficial as Sportsline’s theory that its product was software but not a computer. However, unlike in Fantasy Sports, in this case, no reasonable juror could find that the accused infringer itself makes or uses the entire claimed apparatus. The anchor seat of the device does not contact bone until the surgeon implants it. Because Medtronic is not a direct infringer, we next consider whether Medtronic induces or contributes to infringement. Under § 271(b), “[w]hoever actively induces infringement of a patent shall be liable as an infringer.” 35 U.S.C. § 271(b). “ ‘In order to succeed on a claim of inducement, the patentee must show, first that there has been direct infringement,’ and ‘second, that the alleged in-fringer knowingly induced infringement and possessed specific intent to encourage another’s infringement.’ ” MEMO Elec. Materials, Inc. v. Mitsubishi Materials Silicon Corp., 420 F.3d 1369, 1378 (Fed.Cir.2005) (quoting Minn. Mining & Mfg. Co. v. Chemque, Inc., 303 F.3d 1294, 1304-05 (Fed.Cir.2002)). Under § 271(c), “[w]hoever offers to sell or sells within the United States ... a component of a patented machine, manufacture, combination or composition ... constituting a material part of the invention, knowing the same to be especially made or especially adapted for use in an infringement of such patent, and not a staple article or commodity of commerce suitable for substantial nonin-fringing use, shall be liable as a contributory infringer.” 35 U.S.C. § 271(b). In order to succeed on a claim of contributory infringement, in addition to proving an act of direct infringement, plaintiff must show that defendant “knew that the combination for which its components were especially made was both patented and infringing” and that defendant’s components have “no substantial non-infringing uses.” Golden Blount, Inc. v. Robert H. Peterson Co., 365 F.3d 1054, 1061 (Fed.Cir.2004) (internal quotations omitted). As to the predicate act of direct infringement, we conclude that there is a genuine issue of material fact as to whether surgeons infringe by making the claimed apparatus. The only evidence that Cross Medical cites suggesting that the anchor seat contacts bone is the statement of Medtronic’s employee, Michael Sherman, during his January 29, 2004 deposition: Q. How far down do you screw the screw initially? A. Well, it depends. Because if you screw these screws all the way down, they stop rotating. And the rotating around the ball is a feature of the screw. So you lose some of your ability to rotate, or your freedom. Because the reason these screws have multiple angles is to make it easier to assemble the system in the patient. So if you screw these things down super-tight, you may have — you know, you’ve eliminated the multiaxial capability of the screw. So the surgeon in his judgment gets it down, and I like to tell them, as far as they feel comfortable doing and still have some rotation. Because the further in the instrumentation is into the patient, the lower — the closer the instrumentation is to the loads, and thus the lower the bending moments are on the instrumentation and the less likelihood of metal failure. Q. In practice, in some instances the screw is screwed down such that the receiver touches the bone; is that right? A. I’m sure some surgeons do that. And it can touch the bone and still move a little because the bone is elastic. And the tissue right on top of the bone isn’t necessarily bone. It’s periosteum. It’s deformable. Medtronic counters with an April 22, 2004, declaration from Kevin Foley, M.D., a board certified neurosurgeon, who has performed over 500 operations using Med-tronic’s allegedly infringing products. Dr. Foley states, in pertinent part, that: [i]n all of the surgeries I perform using Medtronic Products, I try to minimize or avoid contact of any part of the receiver member to the patient’s spinal anatomy to ease the eventual implantation of the rod. I do not count on any type of direct connection between the receiver member and the patient’s spine to impart any stability to the spine or to the implant construct.... When implanting the Medtronic Products in a patient’s spine, any contact between the receiver member and any portion of the patient’s anatomy is incidental to the surgery and not intended to impart any stability to the spine. In fact, when I instruct other spine surgeons in how to implant the Medtronic Products, I tell them that if they tighten down on the bone screw enough to bring the receiver member into engagement with the spine, they should back off the bone screw by one-quarter to one-half turn so as to better enable alignment of the receiver members with the rod. Thus, Sherman — who is not testifying that he witnessed contact — speculates that some surgeons may bring the receiver member into contact with bone. Dr. Foley confirms that from time to time, “incidental to the surgery,” the receiver member comes into contact with bone. However, Dr. Foley also suggests that he “tr[ies] to minimize or avoid contact” and instructs others to “back off the bone screw by one quarter to one-half turn” “if they tighten down on the bone screw enough to bring the receiver member into engagement with the spine.” On the one hand, drawing inferences in favor of Medtronic, a reasonable juror could conclude that the apparatus is not made because, more likely than not, there is no contact between the receiver member and the bone. On the other hand, drawing inferences in favor of Cross Medical, a reasonable juror could conclude that the apparatus is made by surgeons. Sherman’s statements suggest that the device is capable of posterior stabilization when the receiver member contacts bone, and the statements of both Sherman and Dr. Foley suggest that there may be some contact between the receiver member and the spine. We leave it to the fact finder to decide whether surgeons directly infringe. As to inducement, there is a genuine issue of material fact bot